Skip to content

Evaluating the efficacy of whitening and spot-removing cosmetic (First method template)

Evaluating the efficacy of whitening and spot-removing cosmetic (First method template)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300067690
Enrollment
Unknown
Registered
2023-01-18
Start date
2022-01-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pigmentation

Interventions

Test product group:Melanization and apply test product
Negative control group:Melanization
Positive control group:Melanization and application of ascorbic acid

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.18-60 years old, healthy male or female; 2. The ITA ° value of skin color at the test site is 20 ° - 41 °; 3. No allergic disease, no history of allergy to cosmetics or other external preparations; 4. No history of photosensitive diseases in the past, and no drugs that affect photosensitivity have been used in the near future; 5. The skin of the tested part should be free of pigmentation, inflammation, scar, pigmented nevus, hirsutism, etc; 6. Those who can accept the tanning of the skin in the test area with artificial light source; 7. Those who can understand the test process, voluntarily participate in the test and sign the written informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women, or those who have a pregnancy preparation plan recently; 2. Have a history of psoriasis, eczema, atopic dermatitis, severe acne and other skin diseases; 3. Those who have taken oral or external corticosteroids and other anti-inflammatory drugs in the past month; 4. Those who have taken orally or externally used any products or drugs (such as hydroquinone preparations) that affect the skin color in the past 2 months; 5. Those who have participated in the same type of test in the past 3 months or participated in the same type of test 3 months ago, but the skin melanization mark of the test site has not completely disappeared; 6. Those who have participated in other clinical trials in recent 2 months; 7. Other persons who are not suitable for the trial according to the clinical evaluation.

Design outcomes

Primary

MeasureTime frame
melanin index;individual type angle;visual skin color assessment;

Countries

China

Contacts

Public ContactLi Li
hxskincosm@qq.com+86 28 8542 2075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026